Inhibition of insulin, glucose-dependant insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity

被引:11
|
作者
Ranganath, LR [1 ]
Beety, JM
Morgan, LM
机构
[1] Epsom Gen Hosp, Dept Chem Pathol, Epsom KT18 7EG, Surrey, England
[2] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
obesity; insulin; GIP; GLP-1; octreotide; heparin; plasma lipoprotein lipase activity;
D O I
10.1055/s-2007-978729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines the immediate effect of modulating postprandial insulin and insulinotropic hormone (glucose-dependent insulinotropic polypeptide, GIP; glucagon-like peptide-1, GLP-1) secretion on the activation of lipoprotein lipase (LPL) in six lean and six obese age-matched women. Subjects were given, on two separate occasions, 340 kcal of carbohydrate alone or combined with an IV infusion of octreotide, (100 mu g infusion from 30 min before the meal for 150 min). Post-heparin LPL activity (10,000 U) was measured on each occasion 120 minutes post-carbohydrate. Following oral carbohydrate postprandial plasma insulin levels were significantly higher in obese subjects than in lean (p<0.01), Glucose tolerance was slightly impaired in obese subjects. Insulin, GIP and GLP-1 secretion post-carbohydrate was markedly reduced by octreotide in lean and obese subjects. LPL activity was similar in the two groups after carbohydrate administration and was unaffected by octreotide. Inhibition of postprandial insulin, GIP and GLP-1 secretion acutely did not reduce post-heparin LPL activity either in lean or obese subjects.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 50 条
  • [31] Clinical Significance of Autoantibody Measurement for Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in the Plasma
    Yamagata, Hiroki
    Onishi, Shunichiro
    Yoshida, Tomohiko
    Hiwasa, Takaki
    Takemoto, Minoru
    DIABETES, 2022, 71
  • [32] Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors
    Balks, HJ
    Holst, JJ
    vonzurMuhlen, A
    Brabant, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03): : 786 - 790
  • [33] Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    Knapper, JME
    Morgan, LM
    Fletcher, JM
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1996, 55 (1B) : 291 - 305
  • [34] Glucagon-like peptide-1 (GLP-1) and leptin secretion after an oral glucose load in obese patients.
    Mannucci, E
    Ognibene, A
    Cremasco, F
    Bardini, G
    Mencucci, A
    Ciani, S
    Pierazzuoli, E
    Rotella, CM
    DIABETOLOGIA, 1999, 42 : A195 - A195
  • [35] ILEAL RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - ASSOCIATION WITH INHIBITION OF GASTRIC-ACID SECRETION IN HUMANS
    LAYER, P
    HOLST, JJ
    GRANDT, D
    GOEBELL, H
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (05) : 1074 - 1082
  • [36] Comparison of the insulinotropic actions of exendin-4 and glucagon-like peptide-1 (GLP-1) during an intravenous glucose challenge in rats
    Parkes, D
    Jodka, L
    Smith, P
    Young, A
    DIABETES, 1999, 48 : A21 - A21
  • [37] Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men
    Feinle, C
    Chapman, IM
    Wishart, J
    Horowitz, M
    PEPTIDES, 2002, 23 (08) : 1491 - 1495
  • [38] Enhanced glucagon-like peptide-1 (GLP-1) secretion leads to rapid improvement of glucose tolerance and insulin secretion after laparoscopic sleeve gastrectomy (LSG)
    Kusunoki, Chisato
    Ugi, Satoshi
    Yamamoto, Hiroshi
    Kamo, Azusa
    Hashimoto, Tetsuya
    Nishio, Yoshihiko
    Kasama, Kazunori
    Tani, Toru
    Kashiwagi, Atsunori
    Maegawa, Hiroshi
    ENDOCRINE JOURNAL, 2010, 57 : S433 - S433
  • [39] Plasma GLP-1 (glucagon-like peptide-1) responses to duodenal fat and glucose infusions in lean and obese men
    Feinle, C
    Chapman, IM
    Wishart, J
    Horowitz, M
    GASTROENTEROLOGY, 2002, 122 (04) : A327 - A327
  • [40] Effect of growth hormone on high plasma levels of glucagon-like peptide-1 (GLP-1) in hypophysectomized rats
    Tateishi, K
    Kitayama, N
    Ishikawa, H
    Mitsudome, A
    Hirose, S
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (07) : 361 - 363